Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#How Will the Genetic Analysis Market Evolve in Terms of Growth and Size by 2029?#_x000D_
In recent times, there has been a significant expansion in the size of the genetic analysis market. With a compound annual growth rate (CAGR) of 13.2%, the market is projected to rise from $9.09 billion in 2024 to $10.29 billion in 2025. The growth experienced during the historic period may be due in part to the increasing occurrence of rare and genetic diseases, as well as the expanding use of genetic testing in the field of oncology. Other factors contributing to this growth include increased demand for bespoke medicine, emphasis on early disease diagnosis and prevention, as well as increased awareness concerning hereditary diseases._x000D_
_x000D_
The anticipation for the genetic analysis market size is a swift expansion in the approaching years. A growth to $16.66 billion is expected by the year 2029 with a compound annual growth rate (CAGR) of 12.8%. The surge in newborn screening programs, the escalating application in managing chronic ailments, an increasing elderly population, a growing emphasis on pediatric genetic testing, and a higher incidence of lifestyle-linked diseases with genetic connections are all contributing factors to this growth in the projected period. The forecasted period also sees prominent trends like fast-paced advancements in next-generation sequencing technologies, the emergence of CRISPR and other gene editing tools, enhancement of bioinformatics and data interpretation instruments, the inclusion of AI and machine learning in genomic data analysis, as well as a transition towards miniaturized sequencing apparatus._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp_x000D_
_x000D_
#What factors are expected to fuel Genetic Analysis market growth in the coming years?#_x000D_
The surge in cancer incidences is anticipated to stimulate the expansion of the genetic analysis market. Cancer is a condition where certain cells in the body multiply without control and have the potentail to spread. The rise in cancer cases can be linked to an aging demographic, which is more susceptible to accruing genetic mutations and enduring exposure to environmental and lifestyle risks which aid cancer development. Genetic analysis plays a critical role in cancer treatment as it identifies specific genetic mutations causing the disease, enabling physicians to administer targeted treatments which are more efficient and have lesser side effects. As an illustration, the National Cancer Institute (NCI), a cancer research and training organization based in the U.S, reported in May 2025 that almost 20 million people across the globe were newly diagnosed with cancer in 2022, and roughly 9.7 million succumbed to the disease. Projections indicate by 2050, the annual count of new cancer cases could hit 33 million, with fatalities from cancer predicted to escalate to 18.2 million. Therefore, the escalating incidences of cancer are propelling the genetic analysis market’s growth._x000D_
_x000D_
#What Are The Key Findings From The Segmentation Analysis Of The Genetic Analysis Market?#_x000D_
The genetic analysis market covered in this report is segmented_x000D_
_x000D_
1) By Product: Reagents And Kits, Instruments, Software_x000D_
2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests_x000D_
3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies_x000D_
4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications_x000D_
5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses_x000D_
_x000D_
Subsegments:_x000D_
1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits_x000D_
2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms_x000D_
3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools_x000D_
_x000D_
#Which Trends Are Expected To Shape The Future Of The Genetic Analysis Market?#_x000D_
Leading businesses in the genetic analysis market are striving to create innovative solutions such as genetic testing options in an effort to promote preventive strategies or encourage early detection. These solutions entail examining an individual’s DNA to identify mutations or variations in genes that may connect to specific health problems or genetic characteristics. For instance, in June 2023, Devyser, a Swedish corporation renowned for designing diagnostic kits, introduced Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing methodologies for hereditary cancer. Devyser LynchFAP is notable for providing a comprehensive technique for evaluating PMS2 and nine extra genes connected to inherited colorectal cancer, thus tackling the challenging task of differentiating PMS2 from its pseudogene PMS2CL. It is the pioneer commercial kit purposely fashioned for an accurate analysis of the PMS2 gene. Devyser BRCA PALB2 facilitates precise detection of genetic changes in BRCA1, BRCA2, and PALB2, which are principal genes linked to a heightened risk of breast and ovarian cancer. Its intuitive design guarantees rapid integration into laboratory procedures and allows for the evaluation of DNA from both blood and tumor specimens in a singular test._x000D_
_x000D_
#What Are The Most Active Companies In The Genetic Analysis Market Today?#_x000D_
Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., and Genebase. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report_x000D_
_x000D_
#Which Regional Markets Are Attracting The Most Investment In Genetic Analysis?#_x000D_
North America was the largest region in the genetic analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27295&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model